Sherlock Biosciences buys Sense Biodetection to boost CRISPR-based diagnostics
The deal will combine Sherlock's advanced CRISPR, synthetic biology and AI technologies with Sense's instrument-free diagnostic hardware and…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
02 Feb 23
The deal will combine Sherlock's advanced CRISPR, synthetic biology and AI technologies with Sense's instrument-free diagnostic hardware and…
02 Feb 23
The new pen injector's small size is complemented by a flexible design with adjustable dosing and push-button colours…
02 Feb 23
NIH-funded technique enables automatic detection of placental compartments, oxygen status and structural abnormalities
01 Feb 23
The new-generation neurostimulator, dubbed Axonics R20, requires to be recharged only once every six to 10 months for…
01 Feb 23
Beckman Coulter has been gained rights to develop and jointly market the MeMed BV test on its Access…
01 Feb 23
The first application in the Guardant Galaxy suite is an AI-backed digital pathology platform created by South Korean…
01 Feb 23
Noninvasively studying the real-time biology of live cells allows scientists to understand the fundamental biological processes underpinning health…
01 Feb 23
Sensorion is a pioneering clinical-stage biotech company, which specializes in the development of novel therapies to restore, treat…
31 Jan 23
Philips intends to execute half of the job cuts this year, and the other half by 2025, to…
31 Jan 23
The company’s first highly recyclable nasal spray pump, APF Futurity, is made using polyolefin materials, eliminating metal parts…